Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Cizzle Biotech (CIZ) Share Price

Price 1.45p on 20-10-2025 at 15:57:07
Change -0.10p -6.45%
Buy 1.60p
Sell 1.30p
Last Trade: Buy 66,666.00 at 1.50p
Day's Volume: 1,994,992
Last Close: 1.45p
Open: 1.55p
ISIN: GB00BNG2VN02
Day's Range 1.40p - 1.55p
52wk Range: 1.25p - 2.65p
Market Capitalisation: £5.75m
VWAP: 1.444955p
Shares in Issue: 396.39m

Cizzle Biotech (CIZ) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 66,666 1.50p Ordinary
14:24:44 - 20-Oct-25
Buy* 350,000 1.488p Ordinary
13:58:49 - 20-Oct-25
Buy* 400,000 1.48p Ordinary
13:50:32 - 20-Oct-25
Buy* 59,704 1.48p Ordinary
13:47:52 - 20-Oct-25
Sell* 306,910 1.35p Ordinary
13:24:25 - 20-Oct-25
Unknown* 300,000 1.45p Ordinary
13:22:59 - 20-Oct-25
Sell* 105,462 1.432p Ordinary
12:32:45 - 20-Oct-25
Buy* 1,143 1.57p Ordinary
11:39:47 - 20-Oct-25
Buy* 43 1.60p Ordinary
10:33:02 - 20-Oct-25
Sell* 375,000 1.43p Ordinary
08:52:00 - 20-Oct-25
See more Cizzle Biotech trades

Cizzle Biotech (CIZ) Share Price History

Time period:
to
Date Open High Low Close Volume
17th Oct 2025 (Fri) 1.55 1.55 1.55 1.55 3,452
16th Oct 2025 (Thu) 1.55 1.55 1.55 1.55 395,859
15th Oct 2025 (Wed) 1.40 1.70 1.35 1.55 4,299,468
14th Oct 2025 (Tue) 1.40 1.40 1.40 1.40 623,606
13th Oct 2025 (Mon) 1.40 1.40 1.40 1.40 117,738
10th Oct 2025 (Fri) 1.40 1.40 1.40 1.40 312,069
9th Oct 2025 (Thu) 1.40 1.40 1.40 1.40 391,368
8th Oct 2025 (Wed) 1.40 1.40 1.40 1.40 108,896
7th Oct 2025 (Tue) 1.40 1.40 1.40 1.40 260,829
6th Oct 2025 (Mon) 1.40 1.40 1.40 1.40 276,681
3rd Oct 2025 (Fri) 1.40 1.40 1.40 1.40 398,662
2nd Oct 2025 (Thu) 1.45 1.45 1.35 1.40 1,806,884
1st Oct 2025 (Wed) 1.50 1.50 1.45 1.45 873,695
30th Sep 2025 (Tue) 1.60 1.60 1.47 1.50 1,654,382
29th Sep 2025 (Mon) 1.80 1.85 1.60 1.60 3,356,265
26th Sep 2025 (Fri) 1.80 1.80 1.80 1.80 579,721
25th Sep 2025 (Thu) 1.80 1.80 1.80 1.80 106,067
24th Sep 2025 (Wed) 1.75 1.80 1.75 1.80 781,131
23rd Sep 2025 (Tue) 1.75 1.75 1.75 1.75 205,126
22nd Sep 2025 (Mon) 1.80 1.80 1.75 1.75 1,979,277
See more Cizzle Biotech price history

Cizzle Biotech (CIZ) Regulatory News

Date Source Headline
30th Sep 2025 7:00 am RNS Interim Results
29th Sep 2025 7:00 am RNS Update on Clinical Laboratory Partnerships in USA
18th Aug 2025 7:00 am RNS Commercial Progress in USA
30th Jun 2025 1:45 pm RNS Result of AGM
6th Jun 2025 11:00 am RNS Notice of AGM
28th May 2025 7:00 am RNS Holding(s) in Company
20th May 2025 7:00 am RNS £150,000 Convertible Loan Note Issue
30th Apr 2025 11:18 am RNS Final results for the year ended 31 December 2024
28th Apr 2025 7:00 am RNS Contract in Caribbean and Update on CIZ1B
14th Apr 2025 10:00 am RNS-R Launch of New Website
See more Cizzle Biotech regulatory news

Cizzle Biotech (CIZ) Share News

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: Capital Metals loss widens; Aptamer's contract

18th Aug 2025 22:11

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: GetsBusy backs sales outlook; Cizzle raises funds

20th May 2025 21:45

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Cizzle Biotechnology appoints Founder Dawn Coverley as CSO

2nd Jan 2025 14:29

Cizzle Biotechnology Holdings PLC - London-based life sciences company engaged in developing a blood test for the early detection of the different forms of lung cancer - Appoints Founder & Non-Executive Director Dawn Coverley as chief scientific officer, effective immediately. Says the new role replaces her position as a NED and accelerates its global licensing and partnership strategy to bring its non-invasive, cost effective, CIZ1B biomarker lung cancer blood test to market in 2025. Read More

EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens

30th Sep 2024 18:37

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

See more Cizzle Biotech news
FTSE 100 Latest
Value9,403.57
Change49.00

Login to your account

Forgot Password?

Not Registered